BRPI0415574A - composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética - Google Patents

composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética

Info

Publication number
BRPI0415574A
BRPI0415574A BRPI0415574-2A BRPI0415574A BRPI0415574A BR PI0415574 A BRPI0415574 A BR PI0415574A BR PI0415574 A BRPI0415574 A BR PI0415574A BR PI0415574 A BRPI0415574 A BR PI0415574A
Authority
BR
Brazil
Prior art keywords
compound
nanoparticle
therapeutic
vaccine
diagnostic
Prior art date
Application number
BRPI0415574-2A
Other languages
English (en)
Inventor
Bernard Pucci
Ange Polidori
Nicolas Michel
Anne-Sylvie Fabiano
Christine Contino-Pepin
Jean-Pierre Salles
Original Assignee
Ts Pharma
Univ D Avignon Et Des Pays Du
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0312390A external-priority patent/FR2861392B1/fr
Priority claimed from FR0405276A external-priority patent/FR2870236B1/fr
Application filed by Ts Pharma, Univ D Avignon Et Des Pays Du filed Critical Ts Pharma
Publication of BRPI0415574A publication Critical patent/BRPI0415574A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38—Cationic compounds
    • C11D1/52—Carboxylic amides, alkylolamides or imides or their condensation products with alkylene oxides
    • C11D1/528—Carboxylic amides (R1-CO-NR2R3), where at least one of the chains R1, R2 or R3 is interrupted by a functional group, e.g. a -NH-, -NR-, -CO-, or -CON- group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"COMPOSTO, NANOPARTìCULA, ASSOCIAçãO DE UMA NANOPARTìCULA COM UM COMPOSTO E COMPOSIçãO TERAPêUTICA, DE DIAGNóSTICO, DE VACINA OU COSMéTICA". Novos compostos tensoativos, sua utilização para a preparação de sistemas supramoleculares metaestáveis, ou nanopartículas. Estas nanopartículas podem ser usadas como vetores de princípios ativos, notadamente princípios ativos terapêuticos.
BRPI0415574-2A 2003-10-23 2004-10-19 composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética BRPI0415574A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0312390A FR2861392B1 (fr) 2003-10-23 2003-10-23 Nouveaux tensio -actifs et leurs applications
FR0405276A FR2870236B1 (fr) 2004-05-14 2004-05-14 Nouveaux tensio-actifs telomeres et leurs applications
PCT/FR2004/002667 WO2005040105A2 (fr) 2003-10-23 2004-10-19 Nouveaux tensio-actifs et leurs applications

Publications (1)

Publication Number Publication Date
BRPI0415574A true BRPI0415574A (pt) 2007-01-02

Family

ID=34524992

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415574-2A BRPI0415574A (pt) 2003-10-23 2004-10-19 composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética

Country Status (7)

Country Link
US (1) US20070275046A1 (pt)
EP (1) EP1708993A2 (pt)
JP (1) JP4989228B2 (pt)
KR (1) KR20060103902A (pt)
BR (1) BRPI0415574A (pt)
RU (1) RU2395493C2 (pt)
WO (1) WO2005040105A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953400B1 (fr) * 2009-12-03 2011-11-18 Oreal Composition cosmetique, composes, kit et procedes de traitement cosmetique
US20110165037A1 (en) * 2010-01-07 2011-07-07 Ismagilov Rustem F Interfaces that eliminate non-specific adsorption, and introduce specific interactions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85420A1 (fr) * 1984-06-18 1986-01-24 Oreal Composes anioniques a deux chaines grasses et compositions les contenant
JPS6171830A (ja) * 1984-09-17 1986-04-12 Dainippon Ink & Chem Inc 界面活性剤組成物
US4836958A (en) * 1986-07-31 1989-06-06 Ciba-Geigy Corporation Fluorinated cationic compounds
US5206027A (en) * 1990-09-13 1993-04-27 Fuji Photo Film Co., Ltd. Amphipathic compound and liposome comprising the same
RU2071765C1 (ru) * 1994-07-14 1997-01-20 Российский научно-исследовательский институт гематологии и трансфузиологии Способ получения липосом
DE19605175A1 (de) * 1996-02-13 1997-08-14 Sourovoi Andrej Dr Lipidverbindungen und deren Verwendung
WO1999035162A1 (en) * 1998-01-07 1999-07-15 Jenner Biotherapies, Inc. Therapeutic liposome-encapsulated immunomodulators

Also Published As

Publication number Publication date
JP4989228B2 (ja) 2012-08-01
WO2005040105B1 (fr) 2005-07-28
WO2005040105A2 (fr) 2005-05-06
US20070275046A1 (en) 2007-11-29
EP1708993A2 (fr) 2006-10-11
WO2005040105A3 (fr) 2005-06-16
RU2395493C2 (ru) 2010-07-27
KR20060103902A (ko) 2006-10-04
JP2007509112A (ja) 2007-04-12
RU2006117528A (ru) 2007-11-27

Similar Documents

Publication Publication Date Title
ATE375142T1 (de) Medizinische aerosolformulierungen
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
MY134568A (en) Cb2 receptor agonists
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
HN2000000267A (es) Oxazolidinonas substituidas y su uso
SE0001899D0 (sv) New compounds
BRPI0416986A (pt) preparação farmacêutica compreendendo um anticorpo contra o receptor de egf
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0102055D0 (sv) New Compounds
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI0412453A (pt) uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0210632A (pt) Tratamento de doença parasìtica
BRPI0415574A (pt) composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Ipc: C07C 323/60 (2006.01), A61K 8/44 (2006.01), A61K 8

B11T Dismissal: dismissal of application maintained